129 related articles for article (PubMed ID: 10894016)
21. Bad Medicine: Polypharmacy.
Spence D
Br J Gen Pract; 2017 Dec; 67(665):562. PubMed ID: 29192108
[No Abstract] [Full Text] [Related]
22. Changing complexities of challenges for clinical practice.
Moore A; Jull G
Man Ther; 2010 Dec; 15(6):513. PubMed ID: 20965429
[No Abstract] [Full Text] [Related]
23. Somnambulating into a paradigm shift--World Changes: Thomas Kuhn and the Nature of Science.
Rashkis HA
JAMA; 1994 Aug; 272(7):515-6. PubMed ID: 8046798
[No Abstract] [Full Text] [Related]
24. Changing clinical practice: messages, messengers, and methods.
Stuart ME
HMO Pract; 1996 Sep; 10(3):100-2. PubMed ID: 10160283
[No Abstract] [Full Text] [Related]
25. Trends and determinants of pharmacotherapy for dyspepsia: analysis of 3-year prescription data in The Netherlands.
Quartero AO; Smeets HM; de Wit NJ
Scand J Gastroenterol; 2003 Jun; 38(6):676-7. PubMed ID: 12825878
[No Abstract] [Full Text] [Related]
26. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
Siegel D; Lopez J; Meier J
Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
[No Abstract] [Full Text] [Related]
27. Low-key, low-cost 'education' for physicians sparks savings.
Montague J
Hosp Health Netw; 1993 Jun; 67(11):70. PubMed ID: 8499972
[No Abstract] [Full Text] [Related]
28. Clinical decision making: from theory to practice. Three battles to watch in the 1990s.
Eddy DM
JAMA; 1993 Jul; 270(4):520-6. PubMed ID: 8320794
[No Abstract] [Full Text] [Related]
29. Sixty seconds on . . . the consultant contract.
Rimmer A
BMJ; 2016 Mar; 352():i1233. PubMed ID: 26935491
[No Abstract] [Full Text] [Related]
30. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
31. The Future of Anesthesia Practice: Pro-Pro-Pro.
Dutton RP; Isaak R; Cammarata BJ; Zvara DA
Adv Anesth; 2019 Dec; 37():111-126. PubMed ID: 31677652
[No Abstract] [Full Text] [Related]
32. Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy.
Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH
Clin Exp Nephrol; 2017 Jun; 21(3):488-496. PubMed ID: 27402286
[TBL] [Abstract][Full Text] [Related]
33. [Use of diuretics in the treatment of circulatory insufficiency].
Vinogradov AV; Sycheva IM; Lobanov NA
Klin Med (Mosk); 1977 Aug; (8):40-5. PubMed ID: 904266
[No Abstract] [Full Text] [Related]
34. "Better" (sometimes) in vascular disease management.
Lawrence PF
J Vasc Surg; 2016 Jan; 63(1):260-9. PubMed ID: 26718826
[No Abstract] [Full Text] [Related]
35. Merck Serono targets convenient, affordable medicines for patients at risk.
Cardiovasc J Afr; 2009; 20(1):77. PubMed ID: 19287822
[No Abstract] [Full Text] [Related]
36. Drug promotion practices: A review.
Jacob NT
Br J Clin Pharmacol; 2018 Aug; 84(8):1659-1667. PubMed ID: 29349812
[TBL] [Abstract][Full Text] [Related]
37. Anticipating things to come.
Schlaff WD; Dlugi AM
Fertil Steril; 2016 Jul; 106(1):48-49. PubMed ID: 27264046
[No Abstract] [Full Text] [Related]
38. Financial incentives and the prescription of newer vaccines by doctors in India.
Lodha R; Bhargava A
Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
[No Abstract] [Full Text] [Related]
39. Medical professionalism in a commercialized health care market.
Relman AS
JAMA; 2007 Dec; 298(22):2668-70. PubMed ID: 18073363
[No Abstract] [Full Text] [Related]
40. US drug marketing: how does promotion correspond with health value?
Greenway T; Ross JS
BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
